Anton A Buzdin Selected Research

Anton A Buzdin Research Topics

17	Neoplasms (Cancer) 08/2023 - 01/2013
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 01/2012
3	Glioblastoma (Glioblastoma Multiforme) 06/2022 - 07/2017
2	Glioma (Gliomas) 06/2022 - 07/2017
2	Leukemia 01/2022 - 11/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2015
2	Infections 12/2016 - 12/2013
1	Inflammation (Inflammations) 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Neuroblastoma 01/2022
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Carcinogenesis 11/2021
1	Brain Neoplasms (Brain Tumor) 07/2017
1	Body Weight (Weight, Body) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Cytomegalovirus Infections (Inclusion Disease) 12/2016
1	Genomic Instability 12/2013
1	Carcinoma (Carcinomatosis) 01/2013

9	Biomarkers (Surrogate Marker)IBA 08/2023 - 01/2013
3	RNA (Ribonucleic Acid)IBA 08/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 08/2022 - 07/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2013
3	MicroRNAs (MicroRNA)IBA 12/2016 - 01/2012
2	Antimicrobial PeptidesIBA 11/2018 - 01/2018
1	p38 Mitogen-Activated Protein KinasesIBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2022
1	ParaffinIBA 08/2022
1	Biocompatible Materials (Biomaterials)IBA 08/2022
1	ulixertinibIBA 01/2022
1	ravoxertinibIBA 01/2022
1	Vx-11eIBA 01/2022
1	LY3214996IBA 01/2022
1	mirdametinibIBA 01/2022
1	SCH772984IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Retroelements (Retrotransposon)IBA 11/2021
1	Zidovudine (Retrovir)FDA LinkGeneric 11/2021
1	efavirenz (Sustiva)FDA Link 11/2021
1	Trypan Blue FDA Link 11/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Single-Domain AntibodiesIBA 07/2017
1	ProteomeIBA 07/2017
1	Cadherins (E-Cadherin)IBA 07/2017
1	ChromatinIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Cetuximab (Erbitux)FDA Link 01/2015